<DOC>
	<DOCNO>NCT00585117</DOCNO>
	<brief_summary>Hypoxia key factor malignant progression neoplasm . It aim explore basis quantitative vivo tumor image Cu-61 diacetyl-bis ( N4-methylthiosemicarbazone ) PET image surrogate tissue hypoxia . We hypothesize hypoxia level predictive tumor response therapy . Patients 2 CU-ATSM PET scan do goal show spatially stable tracer distribution correlate tumor hypoxia . This study serve pilot study PO1 submission</brief_summary>
	<brief_title>Pilot Study ( 61 ) CuATSM-PET Imaging Cancer Patients</brief_title>
	<detailed_description />
	<mesh_term>Esophageal Neoplasms</mesh_term>
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<criteria>Able tolerate PET/CT scan Age 18 old Patient consider XRT treatment cancer Able provide write informed consent severe claustrophobia inability tolerate PET scan pregnant breastfeed woman Patients need supplemental oxygen Patients enrol experimental treatment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2012</verification_date>
</DOC>